Cargando…

Human Bone Marrow Mononuclear Cells Do Not Improve Limb Perfusion in the Hindlimb Ischemia Model

Effective treatments for chronic limb-threatening ischemia are lacking. (Pre)clinical studies on administration of bone marrow (BM) mononuclear cells (MNCs) and BM-derived mesenchymal stromal cells (MSCs) have shown variable results and no studies have directly compared administration of human BM MN...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Rhijn-Brouwer, Femke Christina Ching-Chuan, Gremmels, Hendrik, Den Ouden, Krista, Teraa, Martin, Fledderus, Joost Ougust, Verhaar, Marianne Christina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2022
Materias:	Original Research Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057881/ https://www.ncbi.nlm.nih.gov/pubmed/35152731 http://dx.doi.org/10.1089/scd.2021.0261

Ejemplares similares

Exhaustion of the bone marrow progenitor cell reserve is associated with major events in severe limb ischemia
por: Gremmels, Hendrik, et al.
Publicado: (2019)

Evaluation of bone marrow-derived cell-based therapies in the hindlimb ischaemia model: a protocol for a systematic review and meta-analysis
por: van Rhijn-Brouwer, Femke Christina Ching Chuan, et al.
Publicado: (2021)

Mesenchymal stromal cells for the treatment of critical limb ischemia: context and perspective
por: Gremmels, Hendrik, et al.
Publicado: (2013)

Cell Therapy for Chronic Limb‐Threatening Ischemia: Current Evidence and Future Directions
por: Teraa, Martin, et al.
Publicado: (2018)

Cellular Therapies in Systemic Sclerosis: Recent Progress
por: van Rhijn-Brouwer, Femke C. C., et al.
Publicado: (2016)

Bone Marrow Alterations and Lower Endothelial Progenitor Cell Numbers in Critical Limb Ischemia Patients
por: Teraa, Martin, et al.
Publicado: (2013)

A Pro-Inflammatory Biomarker-Profile Predicts Amputation-Free Survival in Patients with Severe Limb Ischemia
por: Gremmels, Hendrik, et al.
Publicado: (2019)

Mesenchymal Stromal Cell Characteristics and Regenerative Potential in Cardiovascular Disease: Implications for Cellular Therapy
por: van Rhijn-Brouwer, F. C. C., et al.
Publicado: (2018)

Paracrine Proangiogenic Function of Human Bone Marrow-Derived Mesenchymal Stem Cells Is Not Affected by Chronic Kidney Disease
por: van Rhijn-Brouwer, Femke C. C., et al.
Publicado: (2019)

The Transcription Factor Nrf2 Protects Angiogenic Capacity of Endothelial Colony-Forming Cells in High-Oxygen Radical Stress Conditions
por: Gremmels, Hendrik, et al.
Publicado: (2017)

Critical Limb Ischemia: Current Trends and Future Directions
por: Teraa, Martin, et al.
Publicado: (2016)

Ex vivo exposure of bone marrow from chronic kidney disease donor rats to pravastatin limits renal damage in recipient rats with chronic kidney disease
por: van Koppen, Arianne, et al.
Publicado: (2015)

A randomised placebo-controlled double-blind trial to assess the safety of intramuscular administration of allogeneic mesenchymal stromal cells for digital ulcers in systemic sclerosis: the MANUS Trial protocol
por: van Rhijn-Brouwer, Femke C C, et al.
Publicado: (2018)

Recovery of limb perfusion and function after hindlimb ischemia is impaired by arterial calcification
por: Zettervall, Sara L., et al.
Publicado: (2021)

Baseline Platelet Activation and Reactivity in Patients with Critical Limb Ischemia
por: Wisman, Peter Paul, et al.
Publicado: (2015)

Applicability of Transcutaneous Oxygen Tension Measurement in the Assessment of Chronic Limb-Threatening Ischemia
por: Leenstra, Bernard, et al.
Publicado: (2019)

The effect of chronic kidney disease on tissue formation of in situ tissue-engineered vascular grafts
por: Besseling, Paul J., et al.
Publicado: (2023)

Normoxic low‐altitude simulation (at 714 mmHg) improves limb blood perfusion in mice with hindlimb ischemia
por: Shahid, Anmol, et al.
Publicado: (2021)

Intravenous infusion of bone marrow-derived mesenchymal stem cells improves tissue perfusion in a rat hindlimb ischemia model
por: Maeda, Shusaku, et al.
Publicado: (2022)

Growth Differentiation Factor 15 Is Associated With Major Amputation and Mortality in Patients With Peripheral Artery Disease
por: De Haan, Judith J., et al.
Publicado: (2017)

Impaired Endothelial Progenitor Cell Mobilization and Dysfunctional Bone Marrow Stroma in Diabetes Mellitus
por: Westerweel, Peter E., et al.
Publicado: (2013)

Smooth Muscle Progenitor Cells: Friend or Foe in Vascular Disease?
por: van Oostrom, Olivia, et al.
Publicado: (2009)

MicroRNA-133a impairs perfusion recovery after hindlimb ischemia in diabetic mice
por: Chen, Lingdan, et al.
Publicado: (2018)

Combined autologous bone marrow mononuclear cell and gene therapy as the last resort for patients with critical limb ischemia
por: Skóra, Jan, et al.
Publicado: (2014)

Extracellular Matrix Hydrogel Promotes Tissue Remodeling, Arteriogenesis, and Perfusion in a Rat Hindlimb Ischemia Model
por: Ungerleider, Jessica L., et al.
Publicado: (2016)

Exosomes from hypoxic endothelial cells have increased collagen crosslinking activity through up‐regulation of lysyl oxidase‐like 2
por: de Jong, Olivier G., et al.
Publicado: (2015)

T-cells contribute to hypertension but not to renal injury in mice with subtotal nephrectomy
por: Oosterhuis, Nynke R., et al.
Publicado: (2017)

Murine Model of Hindlimb Ischemia
por: Niiyama, Hiroshi, et al.
Publicado: (2009)

Characterization of Mesenchymal Stem Cells of “No-Options” Patients with Critical Limb Ischemia Treated by Autologous Bone Marrow Mononuclear Cells
por: Altaner, Cestmir, et al.
Publicado: (2013)

Relationship between cell number and clinical outcomes of autologous bone-marrow mononuclear cell implantation in critical limb ischemia
por: Yusoff, Farina Mohamad, et al.
Publicado: (2020)

The effects of perfusion conditions on melphalan distribution in the isolated perfused rat hindlimb bearing a human melanoma xenograft.
por: Wu, Z. Y., et al.
Publicado: (1997)

Early Vascular Damage in Young Women with DM-1 and Its Relation to Anti-Müllerian Hormone: A Cross-Sectional Study
por: de Kat, Annelien C., et al.
Publicado: (2016)

The quality and quantity media-cultured mononuclear cell transplantation is safe and effective in ischemic hindlimb mouse model
por: Chinchalongporn, Wanchai, et al.
Publicado: (2023)

Temporal Association Between Ischemic Muscle Perfusion Recovery and the Restoration of Muscle Contractile Function After Hindlimb Ischemia
por: Goldberg, Emma J., et al.
Publicado: (2019)

MicroRNA-210 improves perfusion recovery following hindlimb ischemia via suppressing reactive oxygen species
por: Zhang, Jinfeng, et al.
Publicado: (2020)

Protease nexin-1 deficiency increases mouse hindlimb neovascularisation following ischemia and accelerates femoral artery perfusion
por: Selbonne, Sonia, et al.
Publicado: (2021)

Leakage through the bone-marrow during isolated limb perfusion in the lower extremity
por: Katsarelias, Dimitrios, et al.
Publicado: (2019)

Review of the Long-term Effects of Autologous Bone-Marrow Mononuclear Cell Implantation on Clinical Outcomes in Patients with Critical Limb Ischemia
por: Yusoff, Farina Mohamad, et al.
Publicado: (2019)

Impact of Therapeutic Angiogenesis Using Autologous Bone Marrow-derived Mononuclear Cell Implantation in Patients with No-option Critical Limb Ischemia
por: Yanishi, Kenji, et al.
Publicado: (2020)

Early Sustained Injections of Erythropoietin Improve Angiogenesis and Restoration of Perfusion in the Ischemic Mouse Hindlimb
por: Ahn, Sanghyun, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6piic76ucdd3lmmpbnbalvhttt